Cellular Senescence and Alzheimer Disease: the Egg and the Chicken Scenario

Overview

Journal Nat Rev Neurosci

Specialty Neurology

Date 2020 Jul 1

PMID 32601397

Citations 119

Authors

Sara Saez-Atienzar

Eliezer Masliah

Affiliations

Soon will be listed here.

Abstract

Globally, 50 million people live with dementia, with Alzheimer disease (AD) being responsible for two-thirds of the total cases. As ageing is the main risk factor for dementia-related neurodegeneration, changes in the timing or nature of the cellular hallmarks of normal ageing might be key to understanding the events that convert normal ageing into neurodegeneration. Cellular senescence is a candidate mechanism that might be important for this conversion. Under persistent stress, as occurs in ageing, both postmitotic cells - including neurons - and proliferative cells - such as astrocytes and microglia, among others - can engender a state of chronic cellular senescence that is characterized by the secretion of pro-inflammatory molecules that promote the functional decline of tissues and organs. Ablation of senescent cells has been postulated as a promising therapeutic venue to target the ageing phenotype and, thus, prevent or mitigate ageing-related diseases. However, owing to a lack of evidence, it is not possible to label cellular senescence as a cause or a consequence of neurodegeneration. This Review examines cellular senescence in the context of ageing and AD, and discusses which of the processes - cellular senescence or AD - might come first.

Citing Articles

Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2).

Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X Invest Ophthalmol Vis Sci. 2025; 66(2):15.

PMID: 39913165 PMC: 11806429. DOI: 10.1167/iovs.66.2.15.

Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD.

Wang S, Li B, Li J, Cai Z, Hugo C, Sun Y Mol Neurodegener. 2025; 20(1):15.

PMID: 39901180 PMC: 11792374. DOI: 10.1186/s13024-025-00802-7.

The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer's Disease.

Liu X, Lv Z, Huang Q, Lei Y, Liu H, Xu P Neurochem Res. 2025; 50(1):72.

PMID: 39751972 DOI: 10.1007/s11064-024-04325-3.

Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics.

Venkataraman A, Kordic I, Li J, Zhang N, Bharadwaj N, Fang Z NPJ Aging. 2024; 10(1):57.

PMID: 39592596 PMC: 11599402. DOI: 10.1038/s41514-024-00178-w.

Forkhead box P1 transcriptionally activates IGF-1 to lighten ox-LDL-induced endothelial cellular senescence by inactivating NLRP3 inflammasome.

Deng S, Lao M, Zheng H, Hao J Biogerontology. 2024; 26(1):15.

PMID: 39585426 DOI: 10.1007/s10522-024-10151-5.

References

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H . Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016; 15(5):455-532. DOI: 10.1016/S1474-4422(16)00062-4. View

Ritchie K, Lovestone S . The dementias. Lancet. 2002; 360(9347):1759-66. DOI: 10.1016/S0140-6736(02)11667-9. View

Corriveau R, Koroshetz W, Gladman J, Jeon S, Babcock D, Bennett D . Alzheimer's Disease-Related Dementias Summit 2016: National research priorities. Neurology. 2017; 89(23):2381-2391. PMC: 5719928. DOI: 10.1212/WNL.0000000000004717. View

Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch S, Croteau D . Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15(10):565-581. DOI: 10.1038/s41582-019-0244-7. View

Soto C, Pritzkow S . Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018; 21(10):1332-1340. PMC: 6432913. DOI: 10.1038/s41593-018-0235-9. View

Golde T, Borchelt D, Giasson B, Lewis J . Thinking laterally about neurodegenerative proteinopathies. J Clin Invest. 2013; 123(5):1847-55. PMC: 3635732. DOI: 10.1172/JCI66029. View

Yen S, Dickson D, Crowe A, Butler M, Shelanski M . Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Am J Pathol. 1987; 126(1):81-91. PMC: 1899538. View

Grundke-Iqbal I, Iqbal K, Tung Y, Quinlan M, Wisniewski H, Binder L . Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986; 83(13):4913-7. PMC: 323854. DOI: 10.1073/pnas.83.13.4913. View

Kosik K, Joachim C, Selkoe D . Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1986; 83(11):4044-8. PMC: 323662. DOI: 10.1073/pnas.83.11.4044. View

10.

Glenner G, Wong C . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984; 120(3):885-90. DOI: 10.1016/s0006-291x(84)80190-4. View

11.

Masters C, Simms G, Weinman N, Multhaup G, McDonald B, Beyreuther K . Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985; 82(12):4245-9. PMC: 397973. DOI: 10.1073/pnas.82.12.4245. View

12.

Spillantini M, Schmidt M, Lee V, Trojanowski J, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature. 1997; 388(6645):839-40. DOI: 10.1038/42166. View

13.

Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351(3):602-11. DOI: 10.1016/j.bbrc.2006.10.093. View

14.

Neumann M, Sampathu D, Kwong L, Truax A, Micsenyi M, Chou T . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314(5796):130-3. DOI: 10.1126/science.1134108. View

15.

ElObeid A, Libard S, Leino M, Popova S, Alafuzoff I . Altered Proteins in the Aging Brain. J Neuropathol Exp Neurol. 2016; 75(4):316-25. PMC: 4793886. DOI: 10.1093/jnen/nlw002. View

16.

Wyss-Coray T . Ageing, neurodegeneration and brain rejuvenation. Nature. 2016; 539(7628):180-186. PMC: 5172605. DOI: 10.1038/nature20411. View

17.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

18.

Kennedy B, Berger S, Brunet A, Campisi J, Cuervo A, Epel E . Geroscience: linking aging to chronic disease. Cell. 2014; 159(4):709-13. PMC: 4852871. DOI: 10.1016/j.cell.2014.10.039. View

19.

Baker D, Petersen R . Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Invest. 2018; 128(4):1208-1216. PMC: 5873891. DOI: 10.1172/JCI95145. View

20.

Hayflick L . THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res. 1965; 37:614-36. DOI: 10.1016/0014-4827(65)90211-9. View